drugset / Trial / NCT07173738
Pharmacokinetics, Safety and Tolerability of Concurrent Doses of BIA 5-1058 and Furosemide
RandomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is: * To assess the effect of BIA 5 1058 400 mg on furosemide pharmacokinetics (PK). * To assess the effect of furosemide 40 mg on the PK of BIA 5 1058.
Timeline
- Start
- 2018-06-11
- Primary completion
- 2018-09-07
- Completion
- 2018-09-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Furosemide | Other / unclassified | 40 mg | Oral |
| Subject | zamicastat | Small molecule | 400 mg | Oral |